104 results on '"Zagouri, F"'
Search Results
2. Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma
3. Paraneoplastic pemphigus associated with squamous cell carcinoma of the cervix
4. Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study
5. Immune checkpoint inhibitor administration during pregnancy: a case series
6. How we treat endocrine complications of immune checkpoint inhibitors
7. Metastatic Hepatic Epithelioid Hemangioendothelioma Treated with Olaratumab: A Falling Star Rising?
8. Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
9. ABREAST: a prospective, real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and quality of life of patients with metastatic breast cancer
10. Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting
11. Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial
12. Axitinib as a third or further line of treatment in renal cancer: a single institution experience
13. Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial
14. Current clinical practice guidelines on chemotherapy and radiotherapy for the treatment of non-metastatic muscle-invasive urothelial cancer: A systematic review and critical evaluation by the Hellenic Genito-Urinary Cancer Group (HGUCG)
15. VEGF and Id-1 in pancreatic adenocarcinoma: Prognostic significance and impact on angiogenesis
16. Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: Cell type is the most useful prognostic factor
17. Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: A single institution experience
18. Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma
19. Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel
20. Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement†
21. Fulvestrant and male breast cancer: a case series
22. Imprint cytology of vacuum-assisted breast biopsy specimens: a rapid diagnostic tool in non-palpable solid lesions
23. The emerging role of BET inhibitors in breast cancer.
24. Paving the way for changing perceptions in breast surgery: a systematic literature review focused on oncological and aesthetic outcomes of oncoplastic surgery for breast cancer.
25. The learning curve of breast lesion excision system: Balancing patient's safety and surgical training.
26. P013 - Safety outcomes from monarchE: Phase 3 study of abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER-2-, node-positive, high risk, early breast cancer.
27. Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series.
28. High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer.
29. Platinum derivatives during pregnancy in cervical cancer: a systematic review and meta-analysis.
30. Molecular markers in epithelial ovarian cancer: Their role in prognosis and therapy.
31. Management of advanced stage uterine sarcomas: A bone of contention.
32. Needle Tract Seeding after Vacuum-Assisted Breast Biopsy.
33. Use of fogarty catheter to limit hemorrhage and hematoma after vacuum-assisted breast biopsy.
34. 318P The real-world Hellenic disease management patterns with everolimus (EVE) for women with hormone-receptor-positive (HR+), human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer (aBC): 'The MIRROR' study.
35. Tumor dissemination after laparoscopic surgery for an unsuspected endometrial stromal tumor.
36. What parameters affect pain in core biopsy?
37. SUN-LB040: Overweight, Obesity and Risk of Non-Hodgkin Lymphoma: A Meta-Analysis of Cohort Studies.
38. A Phase 3 Study of Pembrolizumab (Pembro) + Concurrent Chemoradiotherapy (CCRT) for High-Risk Locally Advanced Cervical Cancer (LACC): Safety Findings.
39. LBA30 ATHENA-COMBO, a phase III, randomized trial comparing rucaparib (RUCA) + nivolumab (NIVO) combination therapy vs RUCA monotherapy as maintenance treatment in patients (pts) with newly diagnosed ovarian cancer (OC).
40. P116 Serum levels of Hsp90 in the continuum of breast ductal and lobular lesions.
41. P115 Decreased Hsp90 expression in the continuum of breast lobular lesions.
42. P154 Diagnosis of breast cancer during pregnancy: A five year experience.
43. Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions.
44. 0187 Weekly docetaxel with or without gemcitabine as second line chemotherapy in paclitaxel pretreated patients with metastatic breast cancer: A randomised phase II study conducted by the Hellenic Co-operative oncology group.
45. 0026 Bioptical method: A major predictor of adherence after benign breast biopsy?
46. Cores with microcalcifications in DCIS diagnosis: how many cores make the difference?
47. Hematoma after Vacuum-Assisted Breast Biopsy: A Preventable Condition?
48. Vacuum-Assisted Breast Biopsy: Could It Play a Role in Sentinel Lymph Node Biopsy?
49. Heat shock protein90 in lobular neoplasia of the breast.
50. 709O Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: Overall survival results from the randomized, double-blind, phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.